Malaysia’s BIO International delegation has announced four new deals, including two new investments into Iskandar Malaysia’s Bio-XCell technology park and two partnerships between BioNexus-status companies (see below) and foreign firms.

The two partnerships were: a Technology Licensing Agreement in the bio-refinery sector between Lestari Pacific Sdn Bhd and UK-based Arter Biofuel Products Ltd., and a memorandum of collaboration between Pristine Oil (M) Sdn Bhd and Norway’s Bio Protein AS. The latter deal will establish a new RM608 million (US$20 million) plant in Malaysia to produce a bio-protein to replace fishmeal in the aquaculture industry, according to Business Times.

Pharmaceutical company Agila Specialties (formerly Strides Specialties) Sdn Bhd Americas also announced it would set up a 3.2 hectare facility to produce biopharmaceuticals and sterile injectables at Bio-XCell park for the global market, costing up to $60 million. Meanwhile, Malaysia’s largest industrial gases supplier MOX-Linde also signed a memorandum of collaboration to establish a gas distribution facility at the park. The company plans to extend its facility to include an electronics specialty gases warehouse and separation plant should demand increase.

BioNexus is a government sponsored program awarding special status to biotech companies meeting specified criteria, allowing them to access tax incentives, support programs and a ‘Bill of Guarantees’. Its purpose is to promote international partnerships and commercialization of Malaysian-developed biotechnology. Only 3% of companies in the program have achieved ‘maturity’, determined by workforce and revenue figures, but the plan is to increase this to 5-7% by the end of its first phase in 2015. 188 companies have signed on to date.

sources & article: Business Times, BioTechCorp